Address And Details

P.O. Box 55931 , Boston, MA 02205
Fund Manager Jon Adams
Manager Tenure 6 Years 1 Months

Strategy And Objective

To provide total return primarily from income, secondarily from appreciation. The Adviser constructs an overall portfolio for the Fund consistent with its investment objective by investing substantially, but without limitation, in other BMO mutual funds from a variety of asset classes and supplementing those with unaffiliated funds as considered desirable. The Adviser intends to accomplish the Funds investment objective with the predominant use of the BMO Funds because of the greater familiarity with 1) the capabilities of those investment teams, 2) the consistency of the underlying investment strategy with the Funds overall investment objective, 3) how those BMO Funds will react to aide range of market conditions, and 4) how those strategies will interact with the unaffiliated funds selected or under consideration. Despite the predominant use of BMO Funds for reasons mentioned above, the Adviser has the sole discretion to select unaffiliated funds, including exchange-traded funds, in any asset class as an underlying fund at any time even if a BMO Fund exists in a similar asset class. The Adviser considers numerous factors when selecting the unaffiliated underlying funds, but focuses on how those unaffiliated funds can supplement the BMO Funds already selected.

Net Asset Value

as of 6:12 PM ET 09/24/2021


  • 1 Week
  • -0.25%
  • 1 Month
  • -0.50%
  • 3 Months
  • +0.89%
  • 1 Yr Return
  • +3.67%
  • 5 Yr Return
  • -19.45%

Equity Sector Breakdown

ConsumerDurables n/a
Energy n/a
Finance n/a
Health n/a
IndustrialCyclical n/a
NonDurables n/a
RetailTrade n/a
Services n/a
Technology n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Other 99.51%
Cash 0.49%
Stocks 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 9.34 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 2.46 2.88 n/a
Beta 0.74 0.69 n/a
R Squared 0.16 0.19 n/a
Std Deviation 6.32 5.11 n/a
Sharpe Ratio 0.92 0.85 n/a

Purchase Information

as of 6:23 PM ET 09/22/2021
Minimum Initial $1000
Minimum Additional $50
Minimum Initial IRA $0


Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +8.35%
  • +10.41%
+8.35% +10.41%
3 Year
  • +6.65%
  • +6.65%
+6.65% +6.65%
10 Year
  • n/a
  • n/a
n/a n/a
Life Of Fund
  • +4.32%
  • +4.22%
+4.32% +4.22%

Top 10 Holdings

Symbol Company Name % Of Assets

Recent Articles from TheStreet


Tim Collins on How to Trade Nikola

Technical setups and short interest make much hated name volatile, and therefore interesting.

Chinese Firms Should Face Faster US Stock Delisting Over Audit Rules, SEC Chairman Gary Gensler Tells Lawmakers

Jim Cramer: Gensler's Plate is Very Full

SEC Chairman is key player in efforts to rein in ceaseless financial engineering.

stocks rise asset management sh

Cramer's Mad Money Recap: Advanced Micro Devices, Nvidia, Thor

Jim Cramer has your game plan for next week, which he says will be the calm before the earnings season storm.

Jim Cramer: Starbucks Needs More Traffic in Stores

Starbucks Resists Union Effort in New York Region: Report

Starbucks reportedly said it will raise wages and benefits and a union isn’t needed, to employees at three stores in Buffalo New York.

Exxon Mobil

Exxon, Occidental, Baker Hughes Make Goldman Turnaround List

Exxon has 'reduced costs, surprised to the downside on capital spending, outperformed our expectations in downstream/chemicals,' Goldman said.


Jim Cramer is Tired of the Weak Response to Chip Shortages

Companies need to forget about help from Washington and step up to the plate.

Microsoft Lead

Why 'Sarge' Guilfoyle Isn't Selling His Microsoft

Sharp management and strength across its business lines are keys to software giant.

Why Charles River Labs Is the Biotech Stock to Buy: Jim Cramer

Bret Jensen: Paratek Deal Shows Promise

While antibiotics are usually less profitable and slower to develop market share than other drugs, Paratek has a key factor in its favor.

Stocks Close Higher as Wall Street Dissects New Tax Laws

Stocks End Mixed Amid Evergrande Default Saga, Supply Chain Chaos

Evergrande's default saga, as well as mounting supply chain issues, have stocks trading mixed Friday.

bitcoin copy

Stock Market Today With Jim Cramer: China's Crypto Clampdown

Jim Cramer discusses China's crypto clampdown and Nike's report.